Physician profile
John R Siddoway
NPI 1356338388
$1,679.19
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $380 · 2021: $202 · 2022: $404 · 2023: $356 · 2024: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $566.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $358.10 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $290.15 | 2019-2024 | Dupixent |
| Genzyme Corporation | $234.64 | 2019-2024 | |
| Glaxosmithkline, LLC. | $149.11 | 2022-2024 | Nucala |
| Pharming Healthcare, INC. | $142.62 | 2020-2024 | Ruconest |
| Intersect Ent, INC. | $70.72 | 2020 | |
| Aerin Medical INC. | $66.61 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $46.65 | 2022-2023 | Takhzyro |
| Kaleo, INC. | $46.01 | 2020-2022 | |
| Philips North America LLC | $36.48 | 2020 | |
| Smith+Nephew, INC. | $29.22 | 2022-2023 | Tula |
| Astrazeneca Pharmaceuticals LP | $28.13 | 2021 | |
| Merck Sharp & Dohme LLC | $27.23 | 2023 | |
| Shire North American Group INC | $25.43 | 2019 | |
| Medtronic, INC. | $23.49 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Itamar Medical INC | $18.49 | 2023 | Watchpatone |
| Novartis Pharmaceuticals Corporation | $17.81 | 2019 | |
| Inspire Medical Systems, INC. | $17.46 | 2023 | Inspire |
| Amgen INC. | $17.36 | 2024 | Tavneos |
| Kowa Pharmaceuticals America, INC. | $16.99 | 2023 | Seglentis |
| Stryker Corporation | $16.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Siddoway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.